Schizophrenia.com
FDA Approves VRAYLAR as Adjunctive Therapy for Major Depressive Disorder and AbbVie Announces Reimbursement Program in Canada
Medications
everhopeful
June 7, 2023, 2:14pm
1
1 Like
Related topics
Topic
Replies
Views
Activity
AbbVie Announces Provincial Reimbursement for VRAYLAR® (cariprazine) for the Treatment of Schizophrenia in Québec
Medications
1
296
April 17, 2023
AbbVie's VRAYLAR® (cariprazine) Receives Positive Reimbursement Recommendation by Canada's Drug Agency for the Treatment of Schizophrenia
Medications
0
31
September 4, 2024
Vraylar / cariprazine approved for MDD
News
2
279
December 17, 2022
AbbVie Submits Cariprazine FDA Application for Major Depressive Disorder
Medications
1
256
June 11, 2022
AbbVie's VRAYLAR® (cariprazine) Now Publicly Reimbursed in Alberta
Medications
1
51
September 15, 2025